| 000 | 01710 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518015320.0 | ||
| 264 | 0 | _c20190322 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1643-3750 | ||
| 024 | 7 |
_a10.12659/MSM.913752 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTang, Yutao | |
| 245 | 0 | 0 |
_aEffects of Intermittent Parathyroid Hormone 1-34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women. _h[electronic resource] |
| 260 |
_bMedical science monitor : international medical journal of experimental and clinical research _cJan 2019 |
||
| 300 |
_a259-268 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlendronate _xtherapeutic use |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Resorption _xdrug therapy |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMesenchymal Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteocalcin _xblood |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdrug therapy |
| 650 | 0 | 4 |
_aParathyroid Hormone _xadministration & dosage |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 |
_aTeriparatide _xpharmacology |
| 700 | 1 | _aXia, Han | |
| 700 | 1 | _aKang, Liang | |
| 700 | 1 | _aSun, Quan | |
| 700 | 1 | _aSu, Zhe | |
| 700 | 1 | _aHao, Congqiang | |
| 700 | 1 | _aXue, Yuan | |
| 773 | 0 |
_tMedical science monitor : international medical journal of experimental and clinical research _gvol. 25 _gp. 259-268 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.12659/MSM.913752 _zAvailable from publisher's website |
| 999 |
_c29232186 _d29232186 |
||